A new market analysis indicates steady growth in the global neuropathic pain market, projecting an expansion from USD 7.81 billion in 2023 to USD 14.10 billion by 2031, exhibiting a CAGR of 7.81% during the forecast period of 2024-2031. The market value is estimated to be USD 8.33 billion in 2024. This significant growth is primarily attributed to the rising prevalence of conditions like...